Celldex Therapeutics shares owned by Spire Wealth Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Spire Wealth Management
from 13F filings
Historical chart of Spire Wealth Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Spire Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by Spire Wealth Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $2.1k | 50 | 41.98 |
2023-12-31 | $2.0k | 50 | 40.00 |
2023-09-30 | $1.4k | 50 | 27.52 |
2023-06-30 | $1.7k | 50 | 33.94 |
2023-03-31 | $1.8k | 50 | 35.98 |